Canton Strategic Holdings (CNTN) Liabilities and Shareholders Equity (2020 - 2026)

Canton Strategic Holdings (CNTN) reported Liabilities and Shareholders Equity of $584.7 million for Q1 2026, up 35092.72% on a YoY basis from N/an in Q1 2025, and up 12.62% quarter-over-quarter from $519.1 million in Q4 2025.

Canton Strategic Holdings (CNTN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $584.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 35092.72% year-over-year to $584.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 5796.96% YoY), and the FY2025 full-year result was $519.1 million, up 13849.46% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $584.7 million, up from $519.1 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $584.7 million in Q1 2026, with the low at $1.7 million in Q1 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $70.7 million across 5 years, with a median of $7.7 million in 2025.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity plunged 81.31% — and 2026, when it soared 35092.72%.
  • Canton Strategic Holdings' Liabilities and Shareholders Equity stood at $6.7 million in 2022, then surged by 63.66% to $10.9 million in 2023, then plunged by 66.0% to $3.7 million in 2024, then jumped by 13849.46% to $519.1 million in 2025, then advanced by 12.62% to $584.7 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $584.7 million (Q1 2026), $519.1 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - 584.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 584.65 Mn
Dec 31, 2025 519.15 Mn
Sep 30, 2025 7.70 Mn
Jun 30, 2025 2.53 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 3.72 Mn
Sep 30, 2024 5.25 Mn
Jun 30, 2024 8.26 Mn
Mar 31, 2024 8.89 Mn
Dec 31, 2023 10.95 Mn
Sep 30, 2023 3.17 Mn
Jun 30, 2023 4.60 Mn
Mar 31, 2023 4.72 Mn
Dec 31, 2022 6.69 Mn
Sep 30, 2022 8.02 Mn
Jun 30, 2022 10.25 Mn
Mar 31, 2022 12.09 Mn
Dec 31, 2021 621,677.00
Dec 31, 2020 294,798.00